ZHANG et al., 2009 - Google Patents
'true're‐infection of Helicobacter pylori after successful eradication–worldwide annual rates, risk factors and clinical implicationsZHANG et al., 2009
View PDF- Document ID
- 16811422807014108569
- Author
- ZHANG Y
- XIA H
- ZHUANG Z
- Zhong J
- Publication year
- Publication venue
- Alimentary pharmacology & therapeutics
External Links
Snippet
Background The incidence of 'true're‐infection with Helicobacter pylori after successful eradication remains uncertain. Aim To determine the worldwide rates, risk factors and clinical implications of 'true're‐infection of Helicobacter pylori.'True're‐infection of H. pylori is …
- 241000590002 Helicobacter pylori 0 title abstract description 85
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZHANG et al. | ‘true’re‐infection of Helicobacter pylori after successful eradication–worldwide annual rates, risk factors and clinical implications | |
Stefano et al. | Helicobacter pylori, transmission routes and recurrence of infection: state of the art | |
Oh et al. | The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial | |
Thirumurthi et al. | Helicobacter pylori infection in India from a western perspective | |
Sun et al. | Helicobacter pylori recrudescence and its influencing factors | |
Leja et al. | Epidemiology of Helicobacter pylori infection | |
Herrera et al. | Helicobacter pylori and gastric adenocarcinoma | |
Malaty | Epidemiology of Helicobacter pylori infection. | |
Jin et al. | Systematic review and meta‐analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia | |
Montes et al. | Helicobacter pylori infection in children. Antimicrobial resistance and treatment response | |
Picoli et al. | Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients | |
Bahadori et al. | Presence of gastric Helicobacter species in children suffering from gastric disorders in Southern Turkey | |
Ismail et al. | A newly developed nested PCR assay for the detection of Helicobacter pylori in the oral cavity | |
Streit et al. | Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003) | |
Yari et al. | Loop‐mediated isothermal amplification as a fast noninvasive method of helicobacter pylori diagnosis | |
Pietroiusti et al. | Helicobacter pylori duodenal colonization is a strong risk factor for the development of duodenal ulcer | |
Taneike et al. | Analysis of drug resistance and virulence‐factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status? | |
Lee et al. | First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan | |
Hamidi et al. | Antibiotic resistance and clonal relatedness of Helicobacter pylori strains isolated from stomach biopsy specimens in northeast of Iran | |
Yula et al. | Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA+ status and clinical outcome | |
Adachi et al. | Reinfection rate following effective therapy against Helicobacter pylori infection in Japan | |
Ahmad et al. | Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia | |
Mendoza-Elizalde et al. | Analysis of the genotypic diversity of strains of Helicobacter pylori isolated from pediatric patients in Mexico | |
Reyna-Fabián et al. | Analysis of the bacterial diversity in liver abscess: differences between pyogenic and amebic abscesses | |
Keshavarz Azizi Raftar et al. | The Helicobacter pylori resistance rate to clarithromycin in Iran |